Search

everythinglearnresearchcommunity

for

Search:↓

BAY 43-9006 helps control kidney cancer growth but doesn't significantly increase overall survival.

Combination drug therapy is effective for hirsutism that doesn't improve with just one medication.

Isotretinoin at a low dose for three months does not significantly affect hair growth.

Parental socioeconomic status doesn't improve dietary habits or reduce disease severity in children with sickle cell disease.

Breathing in fine particles or Asian dust short-term doesn't affect schoolchildren's skin symptoms.

Metformin taken during pregnancy increases SHBG in newborns but doesn't change other hormone levels in mothers or babies.

Some breast cancer patients treated with high-dose docetaxel may experience permanent hair loss.

The drug IPI-926 is safe at 160 mg daily and may help treat certain tumors, especially basal cell carcinoma.

Spironolactone helps reduce pain and lesions in hidradenitis suppurativa patients, and lower doses are also effective.

Baricitinib and deuruxolitinib are effective for treating alopecia areata, but their efficacy depends on the dose.

Reducing the dose of Baricitinib to 2mg led to a loss of hair regrowth benefits in nearly half of the patients by Week-104.

Higher doses of isotretinoin may lead to more hair loss.

Taking 1mg of finasteride daily can mildly improve metabolic health and glucose regulation in men with male pattern baldness.

Low-dose oral minoxidil effectively reduces hair loss in women with female pattern hair loss.

"Dutasteride 0.5 mg daily is the most effective treatment for male hair loss."

Finasteride can slow hair loss and promote growth in postmenopausal women.

Taking DHEA for a year is generally safe for postmenopausal women but may cause acne and more facial hair without improving metabolism or aging.

Finasteride effectively and safely treats recurrent priapism in children and adolescents with sickle cell disease.

Ketoconazole cured about 70% of cutaneous leishmaniasis cases caused by Leishmania major.

Tofacitinib may slow hair loss in scarring alopecias but is unlikely to regrow significant hair.

MK-0773 safely increased muscle mass but did not improve muscle strength or function in elderly women with sarcopenia.

Baricitinib helped a woman with severe hair loss regrow almost all her hair without side effects.

Ritlecitinib effectively regrows eyebrow and eyelash hair in alopecia areata, with 50 mg being the best dose.

Transgender females can reach their target estrogen levels using estradiol patches, especially if oral treatments fail or if they're at risk for blood clots. Often, the highest dose patch is needed.

Trilostane effectively and safely treats dogs with pituitary-dependent hyperadrenocorticism, improving symptoms and adrenal gland size.

Isotretinoin effectively treats severe acne and similar conditions, but has common, mostly reversible side effects, requiring careful patient monitoring.

Methotrexate reduced the need for steroids in asthma patients without worsening their condition.

Tofacitinib, a JAK inhibitor, improved hair regrowth in most patients with severe alopecia areata and had minimal side effects.

Teriflunomide is effective and generally safe for treating relapsing multiple sclerosis, reducing relapse rates and disability progression.

Antiandrogen therapies are beneficial for treating skin and hair conditions related to androgen levels.